Phase I Dose Escalation Study of Gemcitabine and 24 Hour Infusion of ON 01910.Na in Patients With Advanced or Metastatic Solid Tumours.
Phase of Trial: Phase I
Latest Information Update: 28 Jun 2017
At a glance
- Drugs Gemcitabine; Rigosertib
- Indications Solid tumours
- Focus Adverse reactions
- 13 Jul 2011 Actual end date (July 2011) added as reported by ClinicalTrials.gov.
- 13 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jul 2010 New trial record